Advertisements

Virginia Tech Researchers Investigate Protein to Enhance Heart Failure Treatments

by Amy

BLACKSBURG, Va. – Cardiovascular scientists at Virginia Tech have identified a promising new approach to treating heart failure. Researchers at the Center for Vascular and Heart Research, part of the Fralin Biomedical Research Institute, discovered that the PERM1 protein significantly improved cardiac function in healthy mice.

“Approximately six million people in the United States suffer from heart failure, and half of these patients do not survive beyond five years after diagnosis. This indicates that current therapies are insufficient,” said Junco Warren, an assistant professor at the institute. “Systolic heart failure occurs when the heart muscle weakens and the mitochondria fail to produce enough energy for the heart to function effectively.”

Advertisements

The PERM1 protein not only strengthens the heart but also regulates its energy output—an ability not matched by existing treatments.

Advertisements

According to the CDC, heart disease remains the leading cause of death in Virginia.

Advertisements

Researchers at Virginia Tech plan to conduct further studies on the effects of the PERM1 protein in failing hearts to determine its potential benefits in clinical settings.

Related topics:

Advertisements

You may also like

blank

Discover heart wellness at CardiovascularDiseaseHub. Your guide to preventive care, expert insights, and a heart-healthy lifestyle. Start your journey to a stronger, happier heart today!

Copyright © 2024 cardiovasculardiseasehub.com